PROTECH HOME MEDICAL ENGAGES OAK HILL FINANCIAL INC. TO PROVIDE INVESTOR RELATIONS SERVICES
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN.
Cincinnati, Ohio – March 14, 2019 – Protech Home Medical Corp. (TSXV: PTQ) (“Protech” or the “Company”) is pleased to announce that it has retained Oak Hill Financial Inc. (“Oak Hill”) to provide investor relations services to the Company in compliance with regulatory guidelines.
Oak Hill is a Toronto-based firm which develops strategic platforms for its clients that are utilized to gain exposure and recognition to the capital markets. Oak Hill provides asset management, capital market and investor relations services. Its team has marketed corporate issuers ranging in market cap from $10M to $1B in a variety of different sectors to the Canadian retail brokerage channel, family offices and institutional networks. Oak Hill’s team of has experience across equity capital markets, equity research, portfolio management, institutional equity sales, and traditional investor relations – resulting in tailored and highly collaborative solutions. Oak Hill is located at 181 Bay Street, Suite 1030 in Toronto.
The Company and Oak Hill act at arm's length, and Oak Hill has no present interest, directly or indirectly, in the Company or its securities. Oak Hill has been engaged on a monthly basis and the fee paid by the Company to Oak Hill (CAD$10,000/month) is for services only. The agreement is subject to approval of the TSX Venture Exchange. “We’re delighted to engage Oak Hill and broaden our reach in our investor relations program,” said Greg Crawford, CEO and Chairman at Protech.
Oak Hill will work closely with Protech to develop and deploy a comprehensive capital markets strategy and campaign. Activities will include providing an investor relations program catering to retail investors, marketing services and an ongoing client services program.
The Company also announces that its board of directors has approved the grant of 200,000 stock options to Oak Hill at an exercise price of $0.90 per common share expiring on March 13, 2021, and vesting quarterly over the first 12 months.